Healthcare Market Research Reports
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
12 Mar 2014  |  Global  |  Market Research
Product and Pipeline Analysis of the Global Psoriasis Therapeutics Market
Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...
$3,950.00 -
24 Feb 2014  |  Global  |  Market Research
Frost & Sullivan Awards for Innovations in Allergy Diagnostics and Treatment--Technical Insights
The dermatology space has been transformed with the introduction of biologic therapy for psoriasis, with several additional novel drug classes on the verge of market introduction. This research service provides a comprehensive overview and analysis of marketed and investigational products for the treatment of psoriasis. Information on market backg...
$3,950.00 -
16 Jan 2014  |  Global  |  Market Research
Analysis of the Global Biosimilars Market
Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth
Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline asse...
$10,000.00 -
09 Jan 2014  |  Global  |  Market Research
Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry
Increasing Volume and Decreasing Value
This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is cover...
$4,950.00 -
19 Dec 2013  |  Global  |  Market Research
Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market
Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...
$2,450.00 -
11 Dec 2013  |  Global  |  Market Research
Analysis of the US Retinal Therapeutics Market
Improvements in Administration and Efficacy Drive Growth
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...
$4,950.00 -
31 Oct 2013  |  Global  |  Market Research
Chinas 2013 Life Sciences Industry Outlook and Regulatory Review
Government Investments Could Make China the Third-largest Pharmaceutical Market in the World
China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...
$4,950.00 -
15 Oct 2013  |  Global  |  Market Research
A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets
High Incidence of Infectious Diseases Persists, While Treatment Options Remain Scarce
Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well...
$3,950.00 -
08 Oct 2013  |  Global  |  Market Research
Global Next Generation Sequencing Informatics Market
Informatics Vendors Flock to Growth in Sequencing Adoption
More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the important trends that affect market growth. Also includ...
$4,950.00 -
24 Sep 2013  |  Europe  |  Market Research
Analysis of the Western and Eastern European Image and Information Management Systems Market
Assessing the Trends and Dynamics of the RIS/PACS Market
The research service is to provide an in-depth analysis of the European Image and Information Management Systems markets. It analyses the revenue potential, market dynamics and trends across Eastern Europe and Western Europe. The European Image and Information Management Systems.
$4,950.00